Manulife (Manufacturers Life Insurance)’s Immuneering IMRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$368K	Hold	69,738	–	–	﹤0.01%	2274
2025 Q4	$469K	Buy	69,738 +464	+0.7%	+$2.98K	﹤0.01%	2205
2025 Q3	$485K	Buy	+69,274	New	+$360K	﹤0.01%	2219
2025 Q2	–	Sell	-82,667	Closed	-$126K	–	2946
2025 Q1	$126K	Buy	82,667 +29	+0%	+$53	﹤0.01%	2641
2024 Q4	$182K	Hold	82,638	–	–	﹤0.01%	2661
2024 Q3	$206K	Hold	82,638	–	–	﹤0.01%	2657
2024 Q2	$106K	Sell	82,638 -4,686	-5%	-$7.7K	﹤0.01%	2809
2024 Q1	$252K	Sell	87,324 -3,858	-4%	-$21.6K	﹤0.01%	2481
2023 Q4	$670K	Hold	91,182	–	–	﹤0.01%	2029
2023 Q3	$700K	Buy	91,182 +595	+0.7%	+$5.47K	﹤0.01%	1950
2023 Q2	$919K	Buy	90,587 +8,040	+10%	+$77.3K	﹤0.01%	1702
2023 Q1	$802K	Hold	82,547	–	–	﹤0.01%	1735
2022 Q4	$409K	Buy	82,547 +11	+0%	+$97	﹤0.01%	2118
2022 Q3	$1.08M	Hold	82,536	–	–	﹤0.01%	1571
2022 Q2	$429K	Sell	82,536 -1,989	-2%	-$10.6K	﹤0.01%	2159
2022 Q1	$573K	Buy	+84,525	New	+$812K	﹤0.01%	2123

Other funds holding IMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IMRX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) held its Immuneering (IMRX) position steady in Q1 2026 at 69,738 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #2274.

Manulife (Manufacturers Life Insurance) first reported a position in IMRX in Q1 2022 and has held it in 16 quarters since. The position peaked at $1.08M in Q3 2022. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

Manulife (Manufacturers Life Insurance) held 69,738 shares of Immuneering worth $368K as of Q1 2026.
Manulife (Manufacturers Life Insurance) left its Immuneering share count unchanged in Q1 2026.
Immuneering made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2274 holding.
Manulife (Manufacturers Life Insurance) first reported a position in Immuneering in Q1 2022 and has held it in 16 quarters since.
Manulife (Manufacturers Life Insurance)'s Immuneering position peaked at $1.08M in Q3 2022.
95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.